Healthcare >> CEO Interviews >> October 17, 2003
JIM A. WRIGHT, President and Chief Executive Officer of Lorus
Therapeutics Inc., was a co-Founder of the biotechnology company,
GeneSense Technologies Inc. At various times during his tenure at Lorus
Therapeutics Inc. he has served as a member of the Board, President and
Chief Scientific Officer and is currently serving as the President and
Chief Executive Officer, and is on the Board of Directors of the
company. In GeneSense, he served at various times as its President,
Chairman of the Board and Chief Scientific Officer. Dr. Wright is
recognized internationally for his work in cancer biology. He has been
Professor of Microbiology in the Faculty of Science, Professor of
Biochemistry and Molecular Biology in the Faculty of Medicine and
Adjunct Professor of Internal Medicine in the Faculty of Medicine at the
University of Manitoba. He has also been Senior Scientist, Associate
Director and Acting Director at the Manitoba Institute of Cell Biology,
Manitoba Cancer Treatment and Research Foundation and has been a
Professor of Medical Biophysics at the University of Toronto. Dr. Wright
has also been a Terry Fox Scientist, a Senior Scientist of the National
Cancer Institute of Canada and up until recently he has been a Terry Fox
Senior Scientist of the National Cancer Institute of Canada. Dr. Wright
has approximately 200 scientific publications to his credit and has co-
authored numerous patent applications. He has also served as an advisor
for various journals, agencies and companies. Profile
Therapeutics?
Dr. Wright: Lorus Therapeutics is a biotech company that's located in
Toronto, Canada. The vision of this company is
